Patients should be warned that concurrent drug use during ibogaine therapy may be fatal.
Approximately 11 people died within 72 hours of ibogaine ingestion as DOA treatment between 1990 and 2006. (Dr. Ken Alper’s studies).
The way a client will metabolize ibogaine is directly related to one’s genetics, thus affecting their ibogaine experience and possibly, the amount of noribogaine made.
Allergic reactions have not been reported